Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

Chayakrit Krittanawong; Bing Yue; Muzamil Khawaja; Anirudh Kumar; Hafeez Ul Hassan Virk; Zhen Wang; Sana Hanif; Umair Khalid; Ali E. Denktas; Clifford J. Kavinsky; John J. Volpi; Hani Jneid

doi:10.1016/j.ijcard.2022.10.135

Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

Chayakrit Krittanawong, Bing Yue, Muzamil Khawaja, Anirudh Kumar, Hafeez Ul Hassan Virk, Zhen Wang, Sana Hanif, Umair Khalid, Ali E. Denktas, Clifford J. Kavinsky, John J. Volpi, Hani Jneid

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.

Original language	English (US)
Pages (from-to)	143-148
Number of pages	6
Journal	International Journal of Cardiology
Volume	370
DOIs	https://doi.org/10.1016/j.ijcard.2022.10.135
State	Published - Jan 1 2023

Keywords

Nationwide readmissions database
Patent foramen ovale
Recurrence
Foramen Ovale, Patent/diagnosis
Humans
Risk Factors
Atrial Flutter
Septal Occluder Device/adverse effects
Atrial Fibrillation/epidemiology
Stroke/etiology
Treatment Outcome
United States/epidemiology
Cardiac Catheterization/adverse effects

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2022.10.135

Cite this

@article{3abd8a403601455f91e87286fac32480,

title = "Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States",

abstract = "Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.",

keywords = "Nationwide readmissions database, Patent foramen ovale, Recurrence, Foramen Ovale, Patent/diagnosis, Humans, Risk Factors, Atrial Flutter, Septal Occluder Device/adverse effects, Atrial Fibrillation/epidemiology, Stroke/etiology, Treatment Outcome, United States/epidemiology, Cardiac Catheterization/adverse effects",

author = "Chayakrit Krittanawong and Bing Yue and Muzamil Khawaja and Anirudh Kumar and Virk, {Hafeez Ul Hassan} and Zhen Wang and Sana Hanif and Umair Khalid and Denktas, {Ali E.} and Kavinsky, {Clifford J.} and Volpi, {John J.} and Hani Jneid",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/j.ijcard.2022.10.135",

language = "English (US)",

volume = "370",

pages = "143--148",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

AU - Krittanawong, Chayakrit

AU - Yue, Bing

AU - Khawaja, Muzamil

AU - Kumar, Anirudh

AU - Virk, Hafeez Ul Hassan

AU - Wang, Zhen

AU - Hanif, Sana

AU - Khalid, Umair

AU - Denktas, Ali E.

AU - Kavinsky, Clifford J.

AU - Volpi, John J.

AU - Jneid, Hani

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.

AB - Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.

KW - Nationwide readmissions database

KW - Patent foramen ovale

KW - Recurrence

KW - Foramen Ovale, Patent/diagnosis

KW - Humans

KW - Risk Factors

KW - Atrial Flutter

KW - Septal Occluder Device/adverse effects

KW - Atrial Fibrillation/epidemiology

KW - Stroke/etiology

KW - Treatment Outcome

KW - United States/epidemiology

KW - Cardiac Catheterization/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=85141773392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141773392&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2022.10.135

DO - 10.1016/j.ijcard.2022.10.135

M3 - Article

C2 - 36356694

AN - SCOPUS:85141773392

SN - 0167-5273

VL - 370

SP - 143

EP - 148

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this